Immunosuppressed are least likely to have COVID-19 antibodies

immunosuppressed

Research identifies that immunosuppressed people are least likely to have COVID-19 antibodies: New research has identified which people with compromised immune systems are less likely to have COVID-19 antibodies – making them more vulnerable to a severe infection. Around one in five people with solid organ transplant, rare autoimmune disease or blood cancer affecting lymphocytes […]

Read More… from Immunosuppressed are least likely to have COVID-19 antibodies

Insights into when COVID-19 patients ARE infectious  

insights

First real-world, peer reviewed study gives detailed new insights into when people with COVID-19 are infectious: Average duration of infectiousness in the study participants was five days Only one in five participants were infectious before COVID-19 symptoms began Two-thirds of cases were still infectious five days after their symptoms began, and one-quarter were still infectious […]

Read More… from Insights into when COVID-19 patients ARE infectious  

School dinners using ultra-processed foods

ultra-processed

Ultra-processed foods make up almost two-thirds of Britain’s school meals: School meals in the UK contain lots of highly processed foods, promoting poor health among children and increasing their risk of obesity. British primary and secondary schoolchildren are getting the majority of their lunchtime calories from ‘ultra-processed’ foods, according to a study led by researchers at […]

Read More… from School dinners using ultra-processed foods

Exciting new medical school for Carlisle

Carlisle

Exciting new medical school for Carlisle announced: University of Cumbria and Imperial College London announce plans for new medical school in Carlisle. The University of Cumbria and Imperial College London are working together to launch a new graduate entry medical school in Carlisle. The new school, which aims to enrol its first students in autumn […]

Read More… from Exciting new medical school for Carlisle

Landmark’ biomedical engineering hub launches in London

hub

Landmark’ biomedical engineering hub launches in London: A major new research facility in White City will drive advances in life-changing medical technologies and treatments. The Sir Michael Uren Hub – one of the world’s most significant centres for biomedical engineering – opens at Imperial College London’s White City Campus today. The state-of-the-art facility was made […]

Read More… from Landmark’ biomedical engineering hub launches in London

Institute launch to tackle infectious disease threats

Institute of infectious diseases

‘Critical mass’ of scientists launches Institute to tackle infectious disease threats: Imperial College London has launched a pioneering new Institute to tackle some of the biggest challenges in infectious disease. The new Institute of Infection brings together one of the largest critical masses of researchers working across infectious disease, anywhere in the world. Building on the […]

Read More… from Institute launch to tackle infectious disease threats

Type 2 diabetes and dementia

dementia

New research could help find ways to prevent dementia in people with type 2 diabetes New research, presented at DUKPC 2021, finds higher blood pressure and cholesterol levels in people with type 2 diabetes who developed dementia, compared with those who did not, up to 20 years before dementia diagnosis A decline in bodyweight, starting […]

Read More… from Type 2 diabetes and dementia

COVID-19 infection in pregnancy not linked with still birth or baby death

COVID-19 infection

COVID-19 infection in pregnancy is not associated with stillbirth or early neonatal death, according to a new study. However the research, from over 4000 pregnant women with suspected or confirmed COVID-19, also found women who had a positive test were more likely to have a premature birth. The research, led by scientists from Imperial College […]

Read More… from COVID-19 infection in pregnancy not linked with still birth or baby death

Statement from the REMAP-CAP trial

Anticoagulant REMAP-CAP

Statement from the REMAP-CAP trial: International Trials of Blood Thinners Pause Enrolment of Critically Ill COVID-19 Patients Three clinical trial platforms working together to test the effects of full doses of anticoagulants (blood thinners) in COVID-19 patients have paused enrolment for one group of patients. Among critically ill COVID-19 patients requiring intensive care unit (ICU) support, […]

Read More… from Statement from the REMAP-CAP trial

Less than 50% willing to get a COVID-19 vaccine

willing to get a COVID-19 vaccine

Less than half of people currently willing to get a COVID-19 vaccine, international survey suggests: A new report on the public’s attitudes towards coronavirus vaccines has revealed that around half of those surveyed (51%) may be willing to get vaccinated next year.  Findings from a survey of 13,500 people across 15 countries* in November suggest that […]

Read More… from Less than 50% willing to get a COVID-19 vaccine